Australia markets closed

Adial Pharmaceuticals, Inc. (ADIL)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.7000+0.0100 (+0.59%)
At close: 04:00PM EDT
1.7001 +0.00 (+0.01%)
After hours: 06:47PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 6.89M
Enterprise value 4.77M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.69
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.69

Trading information

Stock price history

Beta (5Y monthly) 1.53
52-week change 3-77.33%
S&P500 52-week change 323.10%
52-week high 314.0000
52-week low 30.7700
50-day moving average 31.7250
200-day moving average 32.5410

Share statistics

Avg vol (3-month) 36.63M
Avg vol (10-day) 3560.39k
Shares outstanding 54.05M
Implied shares outstanding 64.05M
Float 83.94M
% held by insiders 14.04%
% held by institutions 16.53%
Shares short (15 Apr 2024) 41.01M
Short ratio (15 Apr 2024) 40.14
Short % of float (15 Apr 2024) 425.75%
Short % of shares outstanding (15 Apr 2024) 424.90%
Shares short (prior month 15 Mar 2024) 4105.63k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:25
Last split date 307 Aug 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-82.24%
Return on equity (ttm)-190.27%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -6.89M
Net income avi to common (ttm)-7M
Diluted EPS (ttm)-4.9100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.83M
Total cash per share (mrq)0.7
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)4.90
Book value per share (mrq)2.45

Cash flow statement

Operating cash flow (ttm)-6.81M
Levered free cash flow (ttm)-3.21M